Trends in Cardiovascular Medicine最新文献_第8页

Editorial commentary: Approach to the office patient with apparent resistant or refractory hypertension: Is there a role for renal denervation? 如何诊治明显耐药或难治性高血压患者？肾脏去神经支配有作用吗？

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.09.003

Andrew Foy

引用次数: 0

Editorial commentary: Is it finally prime time for artificial intelligence to improve the care of patients with hypertrophic cardiomyopathy? 人工智能改善肥厚型心肌病患者护理的黄金时期终于到来了吗？

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.08.003

Richard T. Carrick , Ethan J. Rowin

引用次数: 0

Vigorous exercise and sports participation in individuals with hypertrophic cardiomyopathy 肥厚型心肌病患者的剧烈运动和体育锻炼。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.09.004

Belinda Gray , Michael J. Ackerman , Mark S Link , Rachel Lampert

引用次数: 0

Editorial commentary: Exercise recommendations in hypertrophic cardiomyopathy shouldn't end at the recommendation 肥厚性心肌病的运动建议不应止于此。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.12.001

André La Gerche

引用次数: 0

Artificial intelligence-driven electrocardiography: Innovations in hypertrophic cardiomyopathy management 人工智能驱动的心电图：肥厚型心肌病管理的创新。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.08.002

Leopoldo Ordine , Grazia Canciello , Felice Borrelli , Raffaella Lombardi , Salvatore Di Napoli , Roberto Polizzi , Cristina Falcone , Brigida Napolitano , Lorenzo Moscano , Alessandra Spinelli , Elio Masciari , Giovanni Esposito , Maria-Angela Losi

{"title":"Artificial intelligence-driven electrocardiography: Innovations in hypertrophic cardiomyopathy management","authors":"Leopoldo Ordine , Grazia Canciello , Felice Borrelli , Raffaella Lombardi , Salvatore Di Napoli , Roberto Polizzi , Cristina Falcone , Brigida Napolitano , Lorenzo Moscano , Alessandra Spinelli , Elio Masciari , Giovanni Esposito , Maria-Angela Losi","doi":"10.1016/j.tcm.2024.08.002","DOIUrl":"10.1016/j.tcm.2024.08.002","url":null,"abstract":"<div><div>Hypertrophic Cardiomyopathy (HCM) presents a complex diagnostic and prognostic challenge due to its heterogeneous phenotype and clinical course. Artificial Intelligence (AI) and Machine Learning (ML) techniques hold promise in transforming the role of Electrocardiography (ECG) in HCM diagnosis, prognosis, and management.</div><div>AI, including Deep Learning (DL), enables computers to learn patterns from data, allowing for the development of models capable of analyzing ECG signals. DL models, such as convolutional neural networks, have shown promise in accurately identifying HCM-related abnormalities in ECGs, surpassing traditional diagnostic methods.</div><div>In diagnosing HCM, ML models have demonstrated high accuracy in distinguishing between HCM and other cardiac conditions, even in cases with normal ECG findings. Additionally, AI models have enhanced risk assessment by predicting arrhythmic events leading to sudden cardiac death and identifying patients at risk for atrial fibrillation and heart failure. These models incorporate clinical and imaging data, offering a comprehensive evaluation of patient risk profiles. Challenges remain, including the need for larger and more diverse datasets to improve model generalizability and address imbalances inherent in rare event prediction. Nevertheless, AI-driven approaches have the potential to revolutionize HCM management by providing timely and accurate diagnoses, prognoses, and personalized treatment strategies based on individual patient risk profiles.</div><div>This review explores the current landscape of AI applications in ECG analysis for HCM, focusing on advancements in AI methodologies and their specific implementation in HCM care.</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"35 2","pages":"Pages 126-134"},"PeriodicalIF":7.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Contemporary diagnostic approach to arrhythmogenic cardiomyopathy: The three-step work-up 心律失常性心肌病的现代诊断方法：三步工作法。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.09.002

Francesca Graziano , Alessandro Zorzi , Alberto Cipriani , Barbara Bauce , Ilaria Rigato , Martina Perazzolo Marra , Hajnalka Vago , Bela Merkely , Kalliopi Pilichou , Cristina Basso , Domenico Corrado

{"title":"Contemporary diagnostic approach to arrhythmogenic cardiomyopathy: The three-step work-up","authors":"Francesca Graziano , Alessandro Zorzi , Alberto Cipriani , Barbara Bauce , Ilaria Rigato , Martina Perazzolo Marra , Hajnalka Vago , Bela Merkely , Kalliopi Pilichou , Cristina Basso , Domenico Corrado","doi":"10.1016/j.tcm.2024.09.002","DOIUrl":"10.1016/j.tcm.2024.09.002","url":null,"abstract":"<div><div>Arrhythmogenic Cardiomyopathy (ACM) is a cardiac disorder characterized by non-ischemic myocardial scarring, which may lead to ventricular electrical instability and systolic dysfunction. Diagnosing ACM is challenging as there is no single gold-standard test and a combination of criteria is required. The first diagnostic criteria were established in 1994 and revised in 2010, focusing primarily on right ventricular involvement. However, in 2019, an international expert report identified limitations of previous diagnostic scoring and developed the 2020 Padua criteria with also included criteria for diagnosis of left ventricular variants and introduced cardiac magnetic resonance tissue characterization findings for detection of left ventricular myocardial scar. These criteria were further refined and published in 2023 as the European Task Force criteria, gaining international recognition. This review provides an overview of the 20 years of progresses on the disease diagnostic from the original 1994 criteria to the most recent 2023 European criteria, highlighting the evolution into our understanding of the pathobiology and morpho-functional features of the disease.</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"35 2","pages":"Pages 107-113"},"PeriodicalIF":7.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Editorial commentary: Evolving use of quinidine in the treatment of ventricular arrhythmias 奎尼丁在治疗室性心律失常中的应用不断发展。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.08.001

Jeremy Y. Feng, Sanjay Dixit

引用次数: 0

Letter to the Editor: Is oral hydroquinidine a real alternative to intravenous quinidine for intubated patients in intensive care unit? 社论评论：对于重症监护室的插管患者而言，口服氢奎尼丁是静脉注射奎尼丁的真正替代品吗？

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.08.004

Alma Feka, Marianne Cumin, Farshid Sadeghipour

引用次数: 0

The current state and future of renal denervation: A review 肾脏去神经化的现状与未来：回顾。

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.tcm.2024.08.005

Aneel S. Maini, Mansi Maini, Tayo Addo, Vivek Koshti, Thomas Koshy, James A. de Lemos, Angela Price, Dharam J. Kumbhani

引用次数: 0

Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin? 心房颤动与。心房肌病在血栓形成：一个硬币的两面？

IF 7.3 2区医学

Trends in Cardiovascular Medicine Pub Date : 2025-01-24 DOI: 10.1016/j.tcm.2025.01.002

Panteleimon E. Papakonstantinou , José Miguel Rivera-Caravaca , Mauro Chiarito , Hanne Ehrlinder , Panayiotis Iliakis , Aleksandra Gąsecka , Giulio Francesco Romiti , William A.E. Parker , Gregory Y.H. Lip

{"title":"Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?","authors":"Panteleimon E. Papakonstantinou , José Miguel Rivera-Caravaca , Mauro Chiarito , Hanne Ehrlinder , Panayiotis Iliakis , Aleksandra Gąsecka , Giulio Francesco Romiti , William A.E. Parker , Gregory Y.H. Lip","doi":"10.1016/j.tcm.2025.01.002","DOIUrl":"10.1016/j.tcm.2025.01.002","url":null,"abstract":"<div><div>Atrial fibrillation (AF) and atrial myopathy are recognized contributors to cardiovascular morbidity, particularly ischemic stroke. AF poses an elevated risk of thrombogenesis due to irregular heart rhythm leading to blood stasis and clot formation. Atrial myopathy, marked by structural and functional alterations in the atria, is emerging as a crucial factor influencing thromboembolic events, independently of AF. This narrative review article provides an overview of the interwoven relationship between AF and atrial myopathy in thrombogenesis, focusing on the epidemiology, risk factors, and clinical implications of these two entities. The discussion encompasses the association between AF burden and stroke risk, evaluating current evidence and guidelines for anticoagulant therapy. Additionally, it explores the role of atrial myopathy in the pathogenesis of thromboembolic events, emphasizing the patient's clinical profile assessed by the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. The manuscript provides insights into ongoing trials and future perspectives, discussing potential advancements in antithrombotic therapy, fibrin clot dynamics, and anti-inflammatory strategies. This comprehensive review challenges the conventional perception of AF as a sole cause of stroke, urging a holistic approach to risk assessment of thrombogenesis and management in the high-risk population that AF patients constitute.</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"35 5","pages":"Pages 271-281"},"PeriodicalIF":7.3,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143043317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0